Who is sponsoring NCT01682265?

NCT01682265 is sponsored by Nantes University Hospital.

What drugs are being tested in NCT01682265?

Interventions in NCT01682265: Stretta procedure, Sham procedure.

What condition does NCT01682265 study?

NCT01682265 studies Gastroesophageal Reflux Disease.

Is NCT01682265 still recruiting?

NCT01682265 is currently completed. Last updated 29 January 2019.

Last reviewed 2019-01-29 · How we verify

NCT01682265: SIRUP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Stretta In Reflux Uncontrolled by IPP

Completed NA Last updated 29 January 2019

What this trial tests

NA trial testing Stretta procedure in Gastroesophageal Reflux Disease in 62 participants. Completed in 27 November 2018.

Timeline

26 March 2012

Primary endpoint
27 November 2018

27 November 2018

Quick facts

Lead sponsor	Nantes University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	62
Start date	26 March 2012
Primary completion	27 November 2018
Estimated completion	27 November 2018
Sites	6 locations across France

Drugs / interventions tested

Stretta procedure
Sham procedure — full drug profile →

Conditions studied

Gastroesophageal Reflux Disease — all drugs for Gastroesophageal Reflux Disease →

Sponsor

Nantes University Hospital

Who can join

18 and older, any sex, with Gastroesophageal Reflux Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to compare the Stretta procedure and the Sham procedure efficiency 6months post-procedure in reflux uncontrolled by intake of Inhibitors of Protons Pump (IPP) patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Randomised clinical trial: oesophageal radiofrequency energy delivery versus sham for PPI-refractory heartburn.
Zerbib F, Sacher-Huvelin S, Coron E, Coffin B, et al · · 2020 · cited 8× · PMID 32656869 · DOI 10.1111/apt.15936

Verify or expand the search:

Other recruiting trials for Gastroesophageal Reflux Disease

Currently open trials in the same condition.

NCT06783751 — Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG) · NA · recruiting
NCT06348420 — Anti-reflux Mucosal Valvuloplasty Versus PPIs for GERD Treatment · NA · recruiting
NCT06991348 — Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Dise · Phase 4 · recruiting
NCT06732661 — Preserving the Pre-cardial Fat Pad During Sleeve Gastrectomy on Postoperative Gastroesophageal Reflux · NA · active not recruiting
NCT05514769 — Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer · NA · recruiting

Other Nantes University Hospital trials

Trials by the same sponsor.

NCT07278661 — Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery. · Phase 2 · recruiting
NCT06681363 — Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelod · not yet recruiting
NCT07467382 — GOAT (Gait Observation of Achilles Tendon) · not yet recruiting
NCT07490379 — Comparison of the Efficacy of Transcranial Direct Current Stimulation at Home Versus in Hospital Settings in Patients Wi · NA · not yet recruiting
NCT07423481 — Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01682265 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nantes University Hospital
Last refreshed: 29 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01682265.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing